Search Results - "BARETA, J"

Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA by Metcalf, B.J., Chochua, S., Gertz, R.E., Hawkins, P.A., Ricaldi, J., Li, Z., Walker, H., Tran, T., Rivers, J., Mathis, S., Jackson, D., Glennen, A., Lynfield, R., McGee, L., Beall, B., Reingold, A., Brooks, S., Randel, H., Miller, L., White, B., Aragon, D., Barnes, M., Sadlowski, J., Petit, S., Cartter, M., Marquez, C., Wilson, M., Farley, M., Thomas, S., Tunali, A., Baughman, W., Harrison, L., Benton, J., Carter, T., Hollick, R., Holmes, K., Riner, A., Holtzman, C., Danila, R., MacInnes, K., Scherzinger, K., Angeles, K., Bareta, J., Butler, L., Khanlian, S., Mansmann, R., Nichols, M., Bennett, N., Zansky, S., Currenti, S., McGuire, S., Thomas, A., Schmidt, M., Thompson, J., Poissant, T., Schaffner, W., Barnes, B., Leib, K., Dyer, K., McKnight, L., Almendares, O., Hudson, J., McGlone, L., Whitney, C., Schrag, S., Langley, G.

“…Our objective was to evaluate and exploit a whole genome sequence (WGS) bioinformatics pipeline for predicting antimicrobial resistance and capsular serotypes…”
Get full text

Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States by Metcalf, B.J., Chochua, S., Gertz, R.E., Li, Z., Walker, H., Tran, T., Hawkins, P.A., Glennen, A., Lynfield, R., Li, Y., McGee, L., Beall, B., Reingold, A., Brooks, S., Randel, H., Miller, L., White, B., Aragon, D., Barnes, M., Sadlowski, J., Petit, S., Cartter, M., Marquez, C., Wilson, M., Farley, M., Thomas, S., Tunali, A., Baughman, W., Harrison, L., Benton, J., Carter, T., Hollick, R., Holmes, K., Riner, A., Holtzman, C., Danila, R., MacInnes, K., Scherzinger, K., Angeles, K., Bareta, J., Butler, L., Khanlian, S., Mansmann, R., Nichols, M., Bennett, N., Zansky, S., Currenti, S., McGuire, S., Thomas, A., Schmidt, M., Thompson, J., Poissant, T., Schaffner, W., Barnes, B., Leib, K., Dyer, K., McKnight, L., Gierke, R., Almendares, O., Hudson, J., McGlone, L., Langley, G.

“…Our whole genome sequence (WGS) pipeline was assessed for accurate prediction of antimicrobial phenotypes. For 2316 invasive pneumococcal isolates recovered…”
Get full text

A randomized trial of acupuncture as an adjunctive therapy in osteoarthritis of the knee by BERMAN, B. M, SINGH, B. B, LAO, L, LANGENBERG, P, LI, H, HADHAZY, V, BARETA, J, HOCHBERG, M

“…The purpose of this study was to investigate the efficacy of acupuncture as an adjunctive therapy to standard care for the relief of pain and dysfunction in…”
Get full text

Prognostic indicators for development of AIDS among intravenous drug users by Muñoz, A, Vlahov, D, Solomon, L, Margolick, J B, Bareta, J C, Cohn, S, Astemborski, J, Nelson, K E

“…A cohort of 544 human immunodeficiency virus-1 (HIV-1) seropositive intravenous drug users (IVDUs) was recruited in 1988 and early 1989; data on laboratory…”
Get more information

Evidence presented to consensus panel on acupuncture's efficacy by Bareta, J C

Get more information

Prognostic Factors for Survival Differ According to CD4+ Cell Count Among HIV-Infected Injection Drug Users: Pre-HAART and HAART Eras by Galai, Noya, Vlahov, David, Bareta, Joseph C, Wang, Cunlin, Cohn, Sylvia, Sterling, Timothy R

“…To identify prognostic indicators of survival at different CD4 cell levels, independent of highly active antiretroviral therapy (HAART), among injection drug…”
Get full text

Clinical decisions in the use of acupuncture as an adjunctive therapy for osteoarthritis of the knee by Singh, B B, Berman, B M, Hadhazy, V, Bareta, J, Lao, L, Zarow, F M, Hochberg, M

“…To determine whether demographic, medical history, or arthritis assessment data may influence outcome and rate of decay for patients with osteoarthritis…”
Get more information

Zidovudine therapy and health resource utilization in AIDS by Moore, R D, Hidalgo, J, Bareta, J C, Chaisson, R E

“…We wished to determine whether antiretroviral therapy with zidovudine first received when a person is diagnosed with AIDS was associated with diminished or…”
Get more information

Shiga toxin-producing Escherichia coli, New Mexico, USA, 2004-2007 by Lathrop, Sarah, Edge, Karen, Bareta, Joseph

“…Sporadic infection with Shiga toxin-producing Escherichia coli (STEC) in New Mexico increased from 0.9 cases per 100,000 population (95% confidence interval…”
Get full text

A characterization of older AIDS patients in Maryland by WUTOH, A. K, HIDALGO, J, RHEE, W, BARETA, J

“…This retrospective study evaluated Maryland acquired immunodeficiency syndrome (AIDS) patients who were > or = 50 years at the time of AIDS diagnosis. All…”
Get full text

Racial Disparities in Invasive Streptococcus pneumoniae Infections, 1998–2009 by Wortham, Jonathan M., Zell, Elizabeth R., Pondo, Tracy, Harrison, Lee H., Schaffner, William, Lynfield, Ruth, Thomas, Ann, Reingold, Arthur, Bennett, Nancy M., Petit, Susan, Aragon, Deborah, Bareta, Joseph, Juni, Billie A., Farley, Monica M., Beall, Bernard, Moore, Matthew R.

“…Background. Before the introduction of 7-valent pneumococcal conjugate vaccine (PCV7), invasive pneumococcal disease (IPD) rates among blacks were twice the…”
Get full text

A comparison of manual and MEDLARS reviews of the literature on consultation-liaison psychiatry by Bareta, J C, Larson, D B, Lyons, J S, Zorc, J J

“…A systematic manual search for articles related to consultation-liaison psychiatry was compared to a computerized search of the same journals during the same…”
Get more information

Race and the treatment of cytomegalovirus retinitis in a cohort of patients with acquired immunodeficiency syndrome by WUTOH, A. K, HIDALGO, J, BARETA, J, RHEE, W, BEARDSLEY, R, STEIDL, S

“…This historical cohort study assessed the impact of race on critical factors in the diagnosis and drug treatment of cytomegalovirus (CMV) retinitis in acquired…”
Get full text

Mortality in HIV-Seropositive versus -Seronegative Persons in the Era of Highly Active Antiretroviral Therapy: Implications for When to Initiate Therapy by Wang, Cunlin, Vlahov, David, Galai, Noya, Bareta, Joseph, Strathdee, Steffanie A., Nelson, Kenrad E., Sterling, Timothy R.

“…Background. The optimal time to initiate highly active antiretroviral therapy (HAART) remains unclear. Methods. Five hundred eighty-three human…”
Get full text

Mortality risk among new onset injection drug users by Vlahov, David, Wang, Cun-lin, Galai, Noya, Bareta, Joseph, Mehta, Shruti H., Strathdee, Steffanie A., Nelson, Kenrad E.

“…ABSTRACT Aims  To characterize mortality experience among those who only recently started injection. Design  Prospective study. Setting  Independent study…”
Get full text

The effect of HIV infection on overdose mortality by CUNLIN WANG, VLAHOV, David, GALAI, Noya, COLE, Stephen R, BARETA, Joseph, POLLINI, Robin, MEHTA, Shruti H, NELSON, Kenrad E, GALEA, Sandro

“…To quantify the association of HIV infection with overdose mortality and explore the potential mechanisms. A prospective cohort study. A total of 1927 actively…”
Get full text

The construct validity of the ischemic score of Hachinski for the detection of dementias by Larson, D B, Lyons, J S, Bareta, J C, Burns, B J, Blazer, D G, Goldstrom, I D

“…Two hundred forty-one nursing home patients from the National Nursing Home Survey Pretest were assessed using the Ischemic Score of Hachinski. Medical chart…”
Get more information

P0330 HIGH PREVALENCE OF HEPATITIS C VIRUS(HCV) INFECTION IN HOMELESS CAREGIVERS IN BALTIMORE by Schwarz, K. B., Garrett, B., Barnes, P. Y., Ashe, S., Bowser, Y., Bareta, J.

Get full text

P0330 HIGH PREVALENCE OF HEPATITIS C VIRUS(HCV) INFECTION IN HOMELESS CAREGIVERS IN BALTIMORE by Schwarz, K. B., Garrett, B., Barnes, P. Y., Ashe, S., Bowser, Y., Bareta, J.

Get full text

Early-Onset and Late-Onset Neonatal Group B Streptococcal Disease—United States, 1996-2004 by Brooks, S, Apostol, M, Nadle, J, Wymore, K

“…IN 2002, CDC, THE AMERICAN COLLEGE of Obstetricians and Gynecologists (ACOG), and the American Academy of Pediatrics (AAP) issued revised guidelines for…”
Get full text